Mani Mohindru, CFO & Chief Strategy Officer at Cara Therapeutics, Inc. (CARA), sold 4,500 shares at $12.55 ($56K) on 2018-12-28, disclosed to the SEC on 2019-01-02.
Open-market sale of $56k CARA by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CARA | SELL | 2019-12-04 | $162K | — | Filing → |
| CARA | SELL | 2019-07-17 | $936K | — | Filing → |
| CARA | SELL | 2019-05-30 | $107K | — | Filing → |